Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers

International Journal of Molecular Sciences

Volumn 11, Issue 11, 2010, Pages 4488-4505

  Jessie, Kala ^a   Pang, Wei Wei ^a   Rahim, Zubaidah Haji Abdul ^a   Hashim, Onn Haji ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Biomarker; Proteome; Saliva; Smoker

Indexed keywords

ISOPROTEIN; LIPOCALIN 1; SALIVA PROTEIN; THIOREDOXIN;

ADULT; ARTICLE; CHRONIC DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; SALIVA ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS; UNINDEXED SEQUENCE;

BIOMARKER; PROTEOME; SALIVA; SMOKER;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIPOCALINS; MALE; MIDDLE AGED; PROTEOME; SALIVA; SMOKING; THIOREDOXINS;

EID: 78650986185     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11114488     Document Type: Article

References (68)

1. Fellows, J.L.; Trosclair, A.; Adams, E.K.; Rivera, C.C. Annual smoking-attributable mortality, year of potential life lost, and economics costs-United States, 1995-1999. Morbidity Mortality Wkly. Rep. 2002, 51, 300-303.
2. Freedman, N.D.; Leitzmann, M.F.; Hollenbeck, A.R.; Schatzkin, A.; Abnet, C.C. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008, 9, 649-656.
3. Ko, Y.C.; Huang, Y.L.; Lee, C.H.; Chen, M.J.; Lin, L.M.; Tsai, C.C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med. 1995, 24, 450-453.
4. Zheng, T.; Holford, T.; Chen, Y.; Jiang, P.; Zhang, B.; Boyle, P. Risk of tongue cancer associated with tobacco smoking and alcohol consumption. Oral Oncol. 1997, 33, 82-85.
5. Ockene, I.S.; Miller, N.H. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997, 96, 3243-3247.
6. Yoshida, T.; Tuder, R.M. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol. Rev. 2007, 87, 1047-1082.
7. Bergstrom, J. Tobacco smoking and chronic destructive periodontal disease. Odontology 2004, 92, 1-8.
8. Pauly, J.L.; Waight, J.D.; Paszkiewicz, G.M. Tobacco flakes on cigarette filters grow bacteria: A potential health risk to the smoker? Tob. Control 2008, 17,i49-i52.
9. Tobacco smoke and involuntary smoking. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, 11-18 June, 2002; Volume 83.
10. Hasday, J.D.; Bascom, R.; Costa, J.J.; Fitzgerald, T.; Dubin, W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999, 115, 829-835.
11. Lubin, J.H.; Purdue, M.; Kelsey, K.; Zhang, Z.F.; Winn, D.; Wei, Q.; Talamini, R.; Szeszenia-Dabrowska, N.; Sturgis, E.M.; Smith, E.; et al. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Epidemiology 2009, 170, 937-947.
12. Hershkovich, O.; Oliva, J.; Nagler, R.M. Lethal synergistic effect of cigarette smoke and saliva in an in vitro model: Does saliva have a role in the development of oral cancer? Eur. J. Cancer 2004, 40, 1760-1767.
13. Nagler, R.M.; Reznick, A.Z. Cigarette smoke effects on salivary antioxidants and oral cancer-novel concepts. Isr. Med. Assoc. J. 2004, 6, 691-694.
14. Nagler,R.;Dayan, D.The dual role of saliva in oral carcinogenesis. Oncology 2006, 71, 10-17.
15. Reznick, A.Z.; Klein, I.; Eiserich, J.P.; Cross, C.E.; Nagler, R.M. Inhibition of oral peroxidase activity by cigarette smoke: in vivo and in vitro studies. Free Radic. Biol. Med. 2003, 34, 377-384.
16. Ayan, N.; Ayan, I.; Alatli, C.; Guler, S.D.; Dalkilic, C.; Cinar, F.; Dogan, O. P53 overexpression in normal oral mucosa of heavy smokers. J. Exp. Clin. Cancer Res. 2000, 19, 525-529.
17. Wong, D.T. Salivary diagnostics for oral cancer. J. Calif. Dent. Assoc. 2006, 34, 303-308.
18. Hofman, L.F. Human saliva as diagnostic specimen. J. Nutr. 2001,13, 1621S-1625S.
19. Slavkin, H.C. Toward molecular based diagnostic for the oral cavity. J. Am. Dent. Assoc. 1998, 129, 1138-1143.
20. Ferguson, D.B. Saliva as a diagnostic fluid. Acta Stomatologia Croat. 2009, 43, 77-82.
21. Xie, H.; Rhodus, N.L.; Griffin, R.J.; Carlis, J.V.; Griffin, T.J. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol. Cell. Proteomics 2005, 4, 1826-1830.
22. Vitorino, R.; Lobo, M.J.; Ferrer-Correira, A.J.; Dubin, J.R.; Tomer, K.B.; Domingues, P.M.; Amado, F.M. Identification of human whole saliva protein components using proteomics. Proteomics 2004, 4, 1109-1115.
23. Hu, S.; Xie, Y.; Ramachandran, P.; Ogorzalek Loo, R.R.; Li, Y.; Loo, J.A.; Wong, D.T. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel elcetrophoresis-mass spectrometry. Proteomics 2005, 5, 1714-1728.
24. Ghafouri, B.; Tagesson, C.; Lindahl, M. Mapping of proteins in human saliva using two- dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2003, 3, 1003-1015.
25. Huang, C.M. Comparative proteomic analysis of human whole saliva. Arch. Oral Biol. 2004, 49,951-962.
26. Hirtz, C.; Chevalier, F.; Centeno, D.; Egea, J.; Rossignol, M.; Sommerer, N.; de Périère, D. Complexity of the human whole saliva proteome. J. Physiol. Biochem. 2005, 61, 469-480.
27. Wu, Y.; Shu, R.; Luo, L.J.; Ge, L.H.; Xie, Y.F. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J. Periodontal Res. 2009, 44, 636-644.
28. Haigh, B.J.; Stewart, K.W.; Whelan, J.R.; Barnett, M.P.; Smolenski, G.A.; Wheeler, T.T. Alterations in the salivary proteome associated with periodontitis. J. Clin. Periodontol. 2010, 37, 241-247.
29. Giusti, L.; Baldini, C.; Bazzichi, L.; Ciregia, F.; Tonazzini, I.; Mascia, G.; Giannaccini, G.; Bombardieri, S.; Lucacchini, A. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren's syndrome. Proteomics 2007, 7, 1634-1643.
30. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J.A.; Wong, D.T. Salivary proteomic for oral cancer biomarker discovery. Clin. Cancer Res. 2008, 14, 6246-6252.
31. Li, Y.; John, M.A., St.; Zhou, X.; Kim, Y.; Sinha, U.; Jordan, R.C.; Eisele, D.; Abemayor, E.; Elashoff, D.; Park, N.H.; Wong, D.T. Salivary transcriptome diagnostic for oral cancer detection. Clin. Cancer Res. 2004, 10, 8442-8450.
32. Hu, S.; Yu, T.; Xie, Y.; Yang, Y.; Li, Y.; Zhou, X.; Tsung, S.; Loo, R.R.; Loo, J.R.; Wong, D.T. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007, 4, 55-64.
33. Dowling, P.; Wormald, R.; Meleady, P.; Henry, M.; Curran, A.; Clynes, M. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J. Proteomics 2008, 71, 168-175.
34. Ohshiro, K.; Rosenthal, D.I.; Koomen, J.M.; Streckfus, C.F.; Chambers, M.; Kobayashi, R.; El-Naggar, A.K. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int. J. Oncol. 2007, 30, 743-749.
35. Streckfus, C.; Bigler, L.; Tucci, M.; Thigpen, J.T. A preliminary study of cA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000, 18, 101-109.
36. Lindahl, M.; Ekstrom, T.; Sorensen, J.; Tagesson, C. Two dimensional protein patterns of bronchoalveolar lavage fluid from non-smokers, smokers, and subjects exposed to asbestos. Thorax 1996, 51, 1028-1035.
37. Plymoth, A.; Yang, Z.; Lofdahl, C.G.; Ekberg-Jansson, A.; Dahlback, M.; Fehniger, T.E.; Marko-Varga, G.; Hancock, W.S. Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never smokers by micro-scale liquid chromatography and mass spectrometry. Clin. Chem. 2006, 52, 671-679.
38. Plymoth, A.; Lofdahl, C.G.; Ekberg-Jansson, A.; Dahlback, M.; Broberg, P.; Foster, M.; Fehniger, T.E.; Marko-Varga, G. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin. Chem. 2007, 53, 636-644.
39. Ghafouri, B.; Stahlbom, B.; Tagesson, C.; Lindahl, M. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2002, 2, 112-120.
40. Airoldi, L.; Magagnotti, C.; Iannuzzi, A.R.; Marelli, C.; Bagnati, R.; Pastorelli, R.; Colombi, A.; Santaguida, S.; Chiabrando, C.; Schiarea, S.; Fanelli, R. Effects of cigarette smoking on the human urinary proteome. Biochem. Biophys. Res. Commun. 2009, 381, 397-402.
41. Kelsen, S.G.; Duan, X.; Ji, R.; Perez, O.; Liu, C.; Merali, S. Cigarette smoke induced in unfold protein response in the human lung. Am. J. Respir. Cell. Mol. Biol. 2008, 38, 541-550.
42. Gianazza, E.; Allegra, L.; Bucchioni, E.; Eberini, I.; Puglisi, L.; Blasi, F.; Terzano, C.; Wait, R.; Sirtori, C.R. Increassed keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am. J. Med. 2004, 117, 51-54.
43. Jessie, K.; Hashim, O.H.; Rahim, Z.H.A. Precipitation methods for salivary proteins and rehydration buffer for two-dimensional electrophoresis. Biotechnology 2008, 7, 686-693.
44. Heukeshoven, J.; Dernick, R. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988, 9, 28-32.
45. Yan, J.X.; Wait, R.; Berkelman, T.; Harry, R.A.; Westbrook, J.A.; Wheeler, C.H.; Dunn, M.J. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21, 3666-3672.
46. Seriramalu, R.; Pang, W.W.; Jayapalan, J.J.; Mohamed, E.; Abdul-Rahman, P.S.; Bustam, A.Z.; Khoo, A.S.B.; Hashim, O.H. Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasks reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 2010, 31, 2388-2395.
47. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57, 289-300.
48. Humphrey, S.P.; Williamson, R.T. A review of saliva: normal composition, flow, and function. J. Prosthet. Dent. 2001, 85, 162-169.
49. Turner, R.J.; Sugiya, H. Understanding salivary fluid and protein secretion. Oral Dis. 2002, 8, 3-11.
50. Defabianis, P.; Re, F. The role of saliva in maintaining oral health. Minerva Stomatol. 2003, 52, 301-308.
51. Helmerhorst, E.J.; Oppenheim, F.G. Saliva: a dynamic proteome. Critical Reviews in Oral Biology and Medicine. J. Dent. Res. 2007, 86, 680-693.
52. Liu, Y.F.; Xiao, Z.Q.; Li, M.X.; Li, M.Y.; Zhang, P.F.; Li, C.; Li, F.; Chen, Y.H.; Yi, H.; Yao, H.X.; Chen, Z.C. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J. Pathol. 2009, 217, 54-64.
53. Petrova, D.T.; Asif, A.R.; Armstrong, V.W.; Dimova, I.; Toshev, S.; Yaramov, N.; Oellerich, M.; Toncheva, D. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer. Clin. Biochem. 2008, 41, 1224-1236.
54. Gromov, P.; Gromova, I.; Bunkenborg, J.; Cabezon, T.; Moreira, J.M.; Timmermans-Wielenga, V.; Roepstorff, P.; Rank, F.; Celis, J.E. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol. Oncol. 2010, 4, 65-89.
55. Wang, Z.; Feng, X.; Liu, X.; Jiang, L.; Zeng, X.; Ji, N.; Li, J.; Li, L.; Chen, Q. Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis. BMC Genomics 2009, 10, 383.
56. Gupta, N.; Shankernarayan, N.P.; Dharmalingam, K. Alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy. J. Med. Microbiol. 2010, 59, 400-407.
57. Almgren, M.A.E.; Henriksson, K.C.E.; Fujimoto, J.; Chang, C.L. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol. Cancer Res. 2004, 2, 387-394.
58. Allard, L.; Burkhard, P.R.; Lescuyer, P.; Burgess, J.A.; Walter, N.; Hochstrasser, D.F.; Sanchez, J.C. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem. 2005, 51, 2043-2051.
59. Lo, W.Y.; Tsai, M.H.; Tsai, Y.; Hua, C.H.; Tsai, F.J.; Huang, S.Y.; Tsai, C.H.; Lai, C.C. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta 2007, 376, 101-107.
60. O'Donovan, N.; Fischer, A.; Abdo, E.M.; Simon, F.; Peter, H.J.; Gerber, H.; Buergi, U.; Marti, U. Differential expression of IgG Fc binding protein (FcgammaBP) in human normal thyroid tissue, thyroid adenomas and thyroid carcinomas. J. Endocrinol. 2002, 174, 517-524.
61. Whitaker, H.C.; Warren, A.Y.; Eeles, R.; Kote-Jarai, Z.; Neal, D.E. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target. Prostate 2010, 70, 333-340.
62. Esser, D.; Alvarez-Llamas, G.A.; de Vries, M.P.; Weening, D.; Vonk, R.J.; Roelofsen, H. Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic Fluid. Biomark Insights 2008, 3, 25-37.
63. Patti, G.; D'Ambrosio, A.; Mega, S.; Giorgi, G.; Zardi, E.M.; Zardi, D.M.; Dicuonzo, G.; Dobrina, A.; Di Sciascio, G. Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infraction. Journal of the American College of Cardiology. J. Am. Coll. Cardiol. 2004, 43, 35-38.
64. Fearon, W.F.; Fearon, D.T. Inflammation and cardiovascular disease, the role of the interleukin-1 receptor antagonist. Circulation 2008, 117, 2577-2579.
65. Casini-Raggi, V.; Kam, L.; Chong, Y.J.; Fiocchi, C.; Pizarro, T.T.; Cominelli, F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. a novel mechanism of chronic intestinal inflammation. J. Immunol. 1995, 154, 2434-2440.
66. Wojnar, P.; Dirnhofer, S.; Ladurner, P.; Berger, P.; Redl, B. Human lipocalin 1, a physiological scavenger of lipophilic compounds, is produced by corticotrophs of the pituitary gland. J. Histochem. Cytochem. 2002, 50, 433-435.
67. van't Hof, W.; Blankenvoorde, M.F.J.; Veerman, E.C.I.; Amerongen, A.V.N. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor. J. Biol. Chem. 1997, 272, 1837-1841.
68. Huang, Y.L.; Chuang, C.Y.; Sung, F.C.; Chen, C.Y. Thioredoxin overexpression modulates remodeling factors in stress responses to cigarette smoke. J. Toxicol. Environ. Health A 2008, 71, 1490-1498.